BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15613457)

  • 41. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
    Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
    Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.
    Lee JJ; Foukakis T; Hashemi J; Grimelius L; Heldin NE; Wallin G; Rudduck C; Lui WO; Höög A; Larsson C
    Thyroid; 2007 Apr; 17(4):289-301. PubMed ID: 17465858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
    De Falco V; Guarino V; Avilla E; Castellone MD; Salerno P; Salvatore G; Faviana P; Basolo F; Santoro M; Melillo RM
    Cancer Res; 2007 Dec; 67(24):11821-9. PubMed ID: 18089812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
    Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
    Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
    J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth.
    Onda M; Akaishi J; Asaka S; Okamoto J; Miyamoto S; Mizutani K; Yoshida A; Ito K; Emi M
    Br J Cancer; 2005 Jun; 92(12):2216-24. PubMed ID: 15956966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells.
    Xu J; Moatamed F; Caldwell JS; Walker JR; Kraiem Z; Taki K; Brent GA; Hershman JM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4990-6. PubMed ID: 14557485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.
    Visone R; Pallante P; Vecchione A; Cirombella R; Ferracin M; Ferraro A; Volinia S; Coluzzi S; Leone V; Borbone E; Liu CG; Petrocca F; Troncone G; Calin GA; Scarpa A; Colato C; Tallini G; Santoro M; Croce CM; Fusco A
    Oncogene; 2007 Nov; 26(54):7590-5. PubMed ID: 17563749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
    Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
    Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer.
    Akaishi J; Onda M; Asaka S; Okamoto J; Miyamoto S; Nagahama M; Ito K; Kawanami O; Shimizu K
    Anticancer Res; 2006; 26(6B):4437-42. PubMed ID: 17201166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections.
    Thelen P; Burfeind P; Grzmil M; Voigt S; Ringert RH; Hemmerlein B
    Int J Oncol; 2004 May; 24(5):1085-92. PubMed ID: 15067329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.
    Floor SL; Hebrant A; Pita JM; Saiselet M; Trésallet C; Libert F; Andry G; Dumont JE; van Staveren WC; Maenhaut C
    PLoS One; 2014; 9(11):e111581. PubMed ID: 25375362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.
    Schulten HJ; Al-Mansouri Z; Baghallab I; Bagatian N; Subhi O; Karim S; Al-Aradati H; Al-Mutawa A; Johary A; Meccawy AA; Al-Ghamdi K; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S7. PubMed ID: 25923053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers.
    Mengual L; Ars E; Lozano JJ; Burset M; Izquierdo L; Ingelmo-Torres M; Gaya JM; Algaba F; Villavicencio H; Ribal MJ; Alcaraz A
    Actas Urol Esp; 2014 Apr; 38(3):143-9. PubMed ID: 24206626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
    Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
    Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
    Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
    Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
    Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
    Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer.
    Tesselaar MH; Crezee T; Schuurmans I; Gerrits D; Nagarajah J; Boerman OC; van Engen-van Grunsven I; Smit JWA; Netea-Maier RT; Plantinga TS
    J Nucl Med; 2018 May; 59(5):780-786. PubMed ID: 29242405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.